American BriVision (Holding) Corporation (MTOO) financial statements (2021 and earlier)

Company profile

Business Address 44370 OLD WARM SPRINGS BLVD.
FREMONT, CA 94538
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,2731363901241441,036540
Cash and cash equivalents4,2731363901241441,036540
Receivables696633769338334323181
Inventory, net of allowances, customer advances and progress billings      0
Inventory      0
Prepaid expense1721018271775961
Other undisclosed current assets1,031309363270323290452
Total current assets:6,1731,1781,6058028781,7081,234
Noncurrent Assets
Operating lease, right-of-use asset1,7731,843383450524358431
Property, plant and equipment515506508505521514529
Long-term investments and receivables1,1911,1922,1973,2643,3653,2703,335
Long-term investments1,1911,1922,1973,2643,3653,2703,335
Prepaid expense119117115112135131139
Deferred income tax assets1,7911,6491,5801,487   
Other undisclosed noncurrent assets464545441,5041,4231,472
Total noncurrent assets:5,4345,3524,8285,8636,0505,6975,906
TOTAL ASSETS:11,6076,5296,4326,6656,9287,4057,140
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities23238246851320
Accounts payable2323820241320
Employee-related liabilities   4661  
Debt1,7362,0762,6533,2162,3362,2732,447
Due to related parties2885414786374263764,980
Other undisclosed current liabilities2,7973,4064,4363,7783,3673,2152,661
Total current liabilities:4,8446,0467,5747,6556,8145,87810,108
Noncurrent Liabilities
Long-term debt and lease obligation3,9571,531173180236106171
Long-term debt, excluding current maturities2,500      
Operating lease, liability1,4571,531173180236106171
Liabilities, other than long-term debt     688 
Due to related parties     688 
Other undisclosed noncurrent liabilities(1,313)(1,387)(44)3333
Total noncurrent liabilities:2,6441,676302183238797174
Total liabilities:8,9457,7217,8767,8377,0536,67510,282
Stockholders' equity
Stockholders' equity attributable to parent, including:3,438(536)(1,074)(1,137)(151)666(3,321)
Common stock24201919191918
Treasury stock, value(9,100)(9,100)(9,100)(9,100)(9,100)(9,100)(9,100)
Additional paid in capital40,75229,94928,22328,22328,18028,18018,688
Accumulated deficit(25,642)(20,794)(18,948)(17,099)(15,851)(14,774)(13,559)
Stockholders' equity note, subscriptions receivable(3,160)(3,386)(3,612)(3,838)(4,063)(4,289) 
Other undisclosed stockholders' equity attributable to parent5652,7752,344657664629632
Stockholders' equity attributable to noncontrolling interest(776)(655)(370)(36)2664179
Total stockholders' equity:2,662(1,192)(1,444)(1,172)(125)730(3,141)
TOTAL LIABILITIES AND EQUITY:11,6076,5296,4326,6656,9287,4057,140

Income statement (P&L) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues6211622779100198192
Loss on disposition of assets for financial service operations(101)(887)(110)(70)(28)(65)(51)
Cost of revenue(2)(9)(4)(4)(2)(3)(13)
Gross profit:601072227597195178
Operating expenses(4,911)(1,397)(1,416)(1,246)(1,221)(1,311)(667)
Operating loss:(4,851)(1,290)(1,194)(1,171)(1,124)(1,116)(489)
Nonoperating expense(205)(886)(1,039)(178)(19)(166)(166)
Investment income, nonoperating3425(24)16211115
Other nonoperating income (expense)(2)(0)170692(1)2
Interest and debt expense(117)(16)(0)(0)374(0)(133)
Loss from continuing operations before equity method investments, income taxes:(5,172)(2,192)(2,233)(1,350)(769)(1,281)(788)
Other undisclosed income (loss) from continuing operations before income taxes1171600(374)0133
Loss from continuing operations before income taxes:(5,056)(2,176)(2,233)(1,350)(1,143)(1,281)(655)
Income tax expense (benefit)8645494127(49)41
Net loss available to common stockholders, diluted:(4,969)(2,131)(2,184)(1,309)(1,116)(1,330)(614)

Comprehensive Income ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(4,969)(2,131)(2,184)(1,309)(1,116)(1,330)(614)
Comprehensive loss:(4,969)(2,131)(2,184)(1,309)(1,116)(1,330)(614)
Other undisclosed comprehensive income, net of tax, attributable to parent642603245513354118
Comprehensive loss, net of tax, attributable to parent:(4,905)(1,871)(1,860)(1,254)(983)(1,276)(497)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: